Transcriptomic profile of cationic channels in human pulmonary arterial hypertension

Sci Rep. 2021 Aug 4;11(1):15829. doi: 10.1038/s41598-021-95196-z.

Abstract

The dysregulation of K+ channels is a hallmark of pulmonary arterial hypertension (PAH). Herein, the channelome was analyzed in lungs of patients with PAH in a public transcriptomic database. Sixty six (46%) mRNA encoding cationic channels were dysregulated in PAH with most of them downregulated (83%). The principal component analysis indicated that dysregulated cationic channel expression is a signature of the disease. Changes were very similar in idiopathic, connective tissue disease and congenital heart disease associated PAH. This analysis 1) is in agreement with the widely recognized pathophysiological role of TASK1 and KV1.5, 2) supports previous preliminary reports pointing to the dysregulation of several K+ channels including the downregulation of KV1.1, KV1.4, KV1.6, KV7.1, KV7.4, KV9.3 and TWIK2 and the upregulation of KCa1.1 and 3) points to other cationic channels dysregulated such as Kv7.3, TALK2, CaV1 and TRPV4 which might play a pathophysiological role in PAH. The significance of other changes found in Na+ and TRP channels remains to be investigated.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cations / metabolism*
  • Gene Expression Profiling
  • Gene Expression Regulation*
  • Humans
  • Ion Channels / genetics*
  • Kv1.5 Potassium Channel / genetics
  • Pulmonary Arterial Hypertension / genetics*
  • Pulmonary Arterial Hypertension / pathology
  • Transcriptome*

Substances

  • Cations
  • Ion Channels
  • Kv1.5 Potassium Channel